Thomas Geuens

Background

About Thomas Geuens

Visionary biochemist and accomplished executive with a proven track record of steering innovative biotechnology ventures to success. Currently serving as Chief Technology Officer and Head of Clinical Manufacturing at simAbs, I drive the development of ground breaking bio-manufacturing platforms to deliver cost-effective therapeutic monoclonal antibodies for biopharmaceutical companies.With deep expertise in GMP (Good Manufacturing Practices) and a Ph.D. in Biochemistry and Biotechnology, my career spans academic research, international collaborations, and industrial innovation. My doctoral research performed at the Flemish Institute for Biotechnology (VIB) focused on neurogenetics and protein characterization, laying the foundation for a robust understanding of molecular biology and bioprocessing techniques.Previously, as a postdoctoral researcher at the MERLN Institute for Technology-Inspired Regenerative Medicine at Maastricht University, I contributed to a dynamic international consortium bridging academia and industry to achieve translational outcomes in regenerative medicine.I am passionate about leading teams, fostering innovation, and building scalable manufacturing solutions that accelerate the delivery of life-changing therapeutics to patients worldwide. Let’s connect and explore opportunities to advance biotechnology together.